EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today reported financial results for the three and six months ended June 30, 2008. The net loss for the second quarter of 2008 was $24.2 million or $0.45 per basic and diluted share on total revenues of $0.4 million, compared with a net loss of $9.6 million or $0.18 per basic and diluted share on total revenues of $3.1 million for the same period in 2007. The net loss for the first six months of 2008 was $41.8 million or $0.78 per share on total revenues of $1.5 million, compared with a net loss of $17.5 million or $0.33 per share on total revenues of $9.6 million for the same period in 2007. The company ended the quarter with $121.9 million in cash and short and long-term investments.
